National Institute of Pharmaceutical Education & Research, Kolkata Jobs Notification: National Institute of Pharmaceutical Education & Research (NIPER), Kolkata invited applications for the post of Assistant Professor and Other Posts. The eligible candidates can apply to the post through the prescribed format on or before 06 February 2017.
Notification details
Advertisement No. : 02/2017
Important Date:
- Last Date of Application: 06 February 2017
National Institute of Pharmaceutical Education & Research, Kolkata Vacancy Details
- Assistant Professor (Synthetic Biology/ Pharmacology/ Medicinal Chemistry)-01 Post
- Assistant Professor (Pharmaceutics)-01 Post
- Personal Assistant -02 Posts
Eligibility Criteria for Assistant Professor and Other Posts Job
Educational Qualification
- Assistant Professor (Synthetic Biology/ Pharmacology/ Medicinal Chemistry)- First class in M.Pharm./M.S.(Pharm.)/M.Sc. in Life Science with Ph.D degree having teaching/industrial/research experience in the relevant area for a period of three years (Post-Ph.D.)
- Assistant Professor (Pharmaceutics)- First class in M.Pharm./M.S.(Pharm.) in Pharmaceutics with Ph.D degree having teaching/industrial/research experience in the relevant area for a period of three years (Post-Ph.D.)
- Personal Assistant - Post Graduate having at least 10 years experience as Stenographer or Secretarial job in a University/IITs/Research Institute with good communication and computer skill.
Age Limit for Assistant Professor Post Job – 45 Years
Age Limit for Personal Assistant Post Job – 62 Years
How to Apply for the National Institute of Pharmaceutical Education & Research, Kolkata Assistant Professor and Other Posts Jobs 2016
Eligible candidates can apply Online for the posts through the email registrar@niperkolkata.edu.in and directorniperk@gmail.com and send the filled in application along with other necessary required documents to the NIPER-Kolkata at CSIR-IICB Campus. PO. Jadavpur University, Kolkata-700 032. Last date of receipt of application is 06 February 2017.
Comments
All Comments (0)
Join the conversation